These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11212902)

  • 1. Treosulfan chemotherapy for recurrent malignant glioma.
    Schmidt F; Wick W; Herrlinger U; Dichgans J; Weller M
    J Neurooncol; 2000 Sep; 49(3):231-4. PubMed ID: 11212902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.
    Wick W; Hermisson M; Kortmann RD; Küker WM; Duffner F; Dichgans J; Bamberg M; Weller M
    J Neurooncol; 2002 Sep; 59(2):151-5. PubMed ID: 12241108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
    Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trial.
    Neuber K; Reinhold U; Deutschmann A; Pföhler C; Mohr P; Pichlmeier U; Baumgart J; Hauschild A
    Melanoma Res; 2003 Feb; 13(1):81-5. PubMed ID: 12569289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treosulfan in the treatment of metastatic melanoma: from chemosensitivity testing to clinical trials.
    Neuber K
    Recent Results Cancer Res; 2003; 161():159-79. PubMed ID: 12528807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma.
    Chamberlain MC; Tsao-Wei DD; Groshen S
    Cancer; 2006 Jan; 106(1):172-9. PubMed ID: 16323194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Meier W; du Bois A; Reuss A; Kuhn W; Olbricht S; Gropp M; Richter B; Lück HJ; Kimmig R; Pfisterer J
    Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance chemotherapy with oral treosulfan following first-line treatment in patients with advanced ovarian cancer: feasibility and toxicity.
    Meden H; Wittkop Y; Kuhn W
    Anticancer Res; 1997; 17(3C):2221-3. PubMed ID: 9216692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
    Clarke K; Basser RL; Underhill C; Mitchell P; Bartlett J; Cher L; Findlay M; Dalley D; Pell M; Byrne M; Geldard H; Hill JS; Maher D; Fox RM; Green MD; Kaye AH
    J Clin Oncol; 1999 Aug; 17(8):2579-84. PubMed ID: 10561325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.
    Macdonald D; Cairncross G; Stewart D; Forsyth P; Sawka C; Wainman N; Eisenhauer E
    Ann Oncol; 1996 Feb; 7(2):205-7. PubMed ID: 8777179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
    Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
    Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.
    Reber U; Wüllner U; Trepel M; Baumgart J; Seyfried J; Klockgether T; Dichgans J; Weller M
    Biochem Pharmacol; 1998 Feb; 55(3):349-59. PubMed ID: 9484802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
    Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
    J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study.
    Fiorentini G; Sarti D; Milandri C; Dentico P; Mambrini A; Fiorentini C; Mattioli G; Casadei V; Guadagni S
    Integr Cancer Ther; 2019; 18():1534735418812691. PubMed ID: 30580645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma.
    Postma TJ; Heimans JJ; Luykx SA; van Groeningen CJ; Beenen LF; Hoekstra OS; Taphoorn MJ; Zonnenberg BA; Klein M; Vermorken JB
    Ann Oncol; 2000 Apr; 11(4):409-13. PubMed ID: 10847458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.